Eli Lilly Steps Up Pharmacogenetics Effort

By Sally Mardikian PhD

Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)

Published: 6 Nov-2008

DOI: 10.3833/pdr.v2008.i102.109     ISSN: 1756-7874

Section: Licensing



Eli Lilly’s commitment to personalised medicine is demonstrated with its latest agreement with pharmacogenetics company, Cabernet Pharmaceuticals...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details